Literature DB >> 28430046

An Outpatient Methadone Weaning Program by a Neonatal Intensive Care Unit for Neonatal Abstinence Syndrome.

Andrew Lai1, Patrick Philpot2, Jenny Boucher2,3, Andrew Meyer2,4.   

Abstract

Through retrospective chart review, this study described characteristics and length of stay for a cohort of newborns discharged on methadone following an inpatient weaning for neonatal abstinence syndrome (NAS). Data were assessed for all term infants born between January 1, 2010, and December 31, 2014, admitted to the hospital with a co-diagnosis of NAS at discharge, for gestational age, length of stay, days on treatment protocol before discharge, time to once-daily interval methadone dosing, and hospital charges, as well as for categorical characteristics. The 53 patients were predominantly male (58%), white (71%), and covered by Medicaid insurance (72%). Mean gestational age was 39.5 ± 1.1 weeks; length of hospital stay was 11.8 ± 5 days. Common co-diagnoses were newborn feeding problems (26%) and neonatal hypoglycemia (23%). In conclusion, use of the study site's methadone weaning protocol, which can be easily replicated, resulted in a relatively short length of stay and low readmission rates for these patients.

Entities:  

Keywords:  disease management; neonatal abstinence syndrome; opioid abuse; opioid use

Mesh:

Substances:

Year:  2017        PMID: 28430046     DOI: 10.1089/pop.2016.0192

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  2 in total

1.  Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates.

Authors:  Samira Samiee-Zafarghandy; Tamara van Donge; Karel Allegaert; John van den Anker
Journal:  Children (Basel)       Date:  2021-02-25

2.  Outpatient healthcare access and utilization for neonatal abstinence syndrome children: A systematic review.

Authors:  Adam Van Horn; Whitney Powell; Ashley Wicker; Anthony D Mahairas; Liza M Creel; Matthew L Bush
Journal:  J Clin Transl Sci       Date:  2019-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.